Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | RORA | P35398 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31043061 | 1.00 | CA2 (0.36) | CA2CA1CA9RECQLPTGS1 | |
| SCHEMBL537935 | 0.73 | CA2 (0.36) | CA2CA1CA9PTGS1PTGS2 | |
| SCHEMBL29937164 | 0.71 | ALDH1A1 (0.46) | CA2CA1CA9PTGS1KDM4E | |
| SCHEMBL1056365 | 0.71 | ALDH1A1 (0.46) | CA2CA1CA9PTGS1KDM4E | |
| Hydrogen Sulfide SCHEMBL27507715 | 0.70 | ALDH1A1 (0.45) | CA2CA1CA9PTGS1KDM4E | |
| SCHEMBL66198 | 0.69 | CA1 (0.49) | CA2CA1CA9KDM4EALDH1A1 | |
| SCHEMBL2903663 | 0.68 | CA2 (0.36) | CA2CA1CA9RECQLPTGS1 | |
| SCHEMBL9745651 | 0.68 | TDP1 (0.45) | CA2CYP1A2RORCTDP1MEN1 | |
| SCHEMBL718079 | 0.68 | KDM4E (0.38) | CA2CA1CA9RECQLKDM4E | |
| SCHEMBL27574998 | 0.68 | CA1 (0.36) | CA2CA1CA9RECQLPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | claimed |
| EP-4741410-A1 | SOLUBILIZATION GROUP FOR POORLY WATER-SOLUBLE PROTEINS | Glytech, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH INC (JP) | 2024-11-28 | — | — | US | disclosed |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | GLYTECH, INC. (JP) | 2024-10-01 | — | — | US | disclosed |
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH, INC. (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-108884122-B | Method for producing sugar having sulfate group and/or phosphate group | 株式会社糖锁工学研究所 | 2022-06-07 | — | — | CN | disclosed |
| US-10913763-B2 | Method for producing sugar having sulfate group and/or phosphate group | GLYTECH, INC. (JP) | 2021-02-09 | — | — | US | disclosed |
| US-20200062794-A1 | METHOD FOR PRODUCING SUGAR HAVING SULFATE GROUP AND/OR PHOSPHATE GROUP | GLYTECH, INC. (JP) | 2020-02-27 | — | — | US | disclosed |
| EP-3428175-A1 | METHOD FOR PRODUCING SUGAR HAVING SULFATE GROUP AND/OR PHOSPHATE GROUP | Glytech, Inc. (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1740620-A1 | PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005092931-A1 | PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913763-B2 | Method for producing sugar having sulfate group and/or phosphate group | SI, DDOST, PSPH | CA2 176/4885CA1 316/4885CA9 134/4885 |
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | OSTC, B3GAT3, CSGALNACT1 | CA2 3117/4885CA1 2259/4885CA9 745/4885 |
| US-20200062794-A1 | METHOD FOR PRODUCING SUGAR HAVING SULFATE GROUP AND/OR PHOSPHATE GROUP | SI, DDOST, PSPH | CA2 176/4885CA1 316/4885CA9 134/4885 |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | CA2 3748/4885CA1 1977/4885CA9 3418/4885 |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | QPCT, QPCTL, PTMS | CA2 3639/4885CA1 1695/4885CA9 3184/4885 |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | CA2 3748/4885CA1 1977/4885CA9 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.